Trial intelligence / Profile preview

Levonorgestrel Vaginal System for Contraception

NCT07734155Phase 3Not yet recruiting

Sponsor
Chemo
Start
Dec 2026
Primary completion
Dec 2030
01

Overview

A Phase 3 trial of avatrombopag in contraception, sponsored by Chemo. Planned start Dec 2026; status: not yet recruiting.

02

Drugs

avatrombopag
03

Conditions

contraception

Beyond the preview

Go deeper on NCT07734155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07734155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call